Clinical Trials
2 trialsNCT06731699 2024-12-17
A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS
Chengdu FenDi Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT02418000 2019-03-20
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
Spirita Oncology, LLC
Phase 1/2 Terminated